6th Annual Conference – A Thoughtful Approach to Pain Management

event-banner

If Not Opiods, Then What?

Registration Now Open

3 days of in-depth, practical and leading-edge medical education by world-class pain medicine experts.

Overview:
Experts from around the country will lead a dynamic, multi-faceted educational experience, including “TED” talks, small discussion groups, panel discussions, breakout sessions, and extended learning opportunities. Participants will learn how to approach the treatment of chronic non-cancer pain from a collaborative, multidisciplinary, non-opioid perspective, based upon current research and best practices.

Learning Objectives:

By the completion of this program participants will:

  • Understand the principles and best practices of chronic pain management.
  • Learn how to better screen individuals who present with chronic pain and to create an appropriate management regime.
  • Learn effective communication strategies for dealing with chronic pain patients, and in order to help them become motivated and engaged to make long-term changes to their health.

Intended Audience:
Physicians, PAs, NPs, nurses, psychiatrists, psychologists, pharmacists, social workers, counselors, substance abuse treatment professionals, PT, OT, administrators, and other health care professionals who treat patients with chronic pain.

Email: PainConference2017@oregonpainguidance.org

Oregon Medical Association

Live Webcast – Opioids: Current and Future Directions for Addressing the Crisis

Dr. Scott K. Winiecki from the FDA’s Center for Drug Evaluation and Research Safe Use Team will present on “Opioids: Current and Future Directions for Addressing the Crisis.”  He will discuss how the current situation evolved and focus on actions taken by the FDA to address the issues of opioid use, misuse, and abuse.  In addition, he will review interventions from other sources, including academic researchers, state Prescription Drug Monitoring Programs, and other Federal Agencies.  Specific approaches to be discussed will include the role of abuse deterrent formulations, the use of prescriber feedback, and the wider distribution of naloxone.  Finally, Dr. Winiecki will touch upon possible directions and interventions that may be employed in the future.